|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4800 AUD | 0.00% |
|
-4.00% | -26.15% |
| Market Cap | 139M 97.32M 84.85M 78.59M 73.57M 138M 9.18B 932M 361M 4.52B 365M 357M 15.69B | P/E 2026 * |
-6.76x | P/E 2027 * | -4.42x |
|---|---|---|---|---|---|
| Enterprise Value | 147M 103M 89.84M 83.2M 77.89M 146M 9.72B 987M 383M 4.79B 387M 378M 16.62B | EV / Sales 2026 * |
19.1x | EV / Sales 2027 * | 19.4x |
| Free-Float |
57.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -4.00% | ||
| Current month | -12.73% | ||
| 1 month | -2.04% | ||
| 3 months | -1.03% | ||
| 6 months | -19.33% | ||
| Current year | -26.15% |
| 1 week | 0.48 |  | 0.51 |
| 1 month | 0.48 | | 0.59 |
| Current year | 0.42 | | 0.73 |
| 1 year | 0.28 | | 0.73 |
| 3 years | 0.28 | | 0.78 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-24 | Expiration | Chief Executive Officer | 2,250,000 | 0.7781% | ||
| 14/10/25 | Expiration | Chief Executive Officer | 745,962 | 0.3217% | ||
| 21/11/24 | Buy | Chairman | 2,650,000 | 1.1429% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -4.00% | +62.71% | -20.00% | 97.32M | |
| -1.21% | -3.04% | +39.94% | +145.38% | 980B | |
| -2.48% | -5.18% | +51.52% | +39.07% | 550B | |
| -2.14% | -4.94% | +16.71% | +56.15% | 382B | |
| +0.25% | -3.09% | +23.00% | +15.81% | 316B | |
| +0.61% | -1.69% | +25.42% | +13.64% | 272B | |
| +0.22% | -3.10% | +24.25% | +30.21% | 268B | |
| +4.59% | +1.98% | -40.02% | -45.89% | 199B | |
| -1.19% | -4.95% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.46% | +14.59% | +56.94% | 154B | |
| Average | -0.27% | -3.11% | +23.47% | +33.83% | 330.24B | |
| Weighted average by Cap. | -0.78% | -3.68% | +27.80% | +63.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.68M 5.38M 4.69M 4.35M 4.07M 7.63M 508M 51.55M 19.98M 250M 20.2M 19.77M 868M | 8.86M 6.21M 5.42M 5.02M 4.7M 8.81M 586M 59.52M 23.07M 289M 23.32M 22.82M 1B |
| Net income | -20.45M -14.34M -12.5M -11.58M -10.84M -20.32M -1.35B -137M -53.22M -666M -53.81M -52.66M -2.31B | -30.9M -21.67M -18.89M -17.5M -16.38M -30.72M -2.04B -208M -80.44M -1.01B -81.32M -79.58M -3.49B |
| Net Debt | 8.15M 5.71M 4.98M 4.61M 4.32M 8.1M 539M 54.74M 21.21M 265M 21.45M 20.99M 921M | 33.53M 23.51M 20.5M 18.98M 17.77M 33.33M 2.22B 225M 87.28M 1.09B 88.24M 86.35M 3.79B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/06/26 | 0.4800 $ | 0.00% | 65,703 |
| 18/06/26 | 0.4800 $ | -5.88% | 149,531 |
| 17/06/26 | 0.5100 $ | +3.03% | 59,596 |
| 16/06/26 | 0.4950 $ | -1.98% | 81,561 |
| 15/06/26 | 0.5050 $ | +1.00% | 4,797 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
